$265.63
0.000.00%
Pre-Market: 4:00 PM EDT
Bio-Rad Laboratories reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bio-Rad Laboratories using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-13 | $2.90 | $2.88 | 0.69 % |
Q3 | 2024-10-30 | $2.01 | $1.16 | 73.3 % |
Q2 | 2024-08-01 | $3.11 | $2.01 | 54.7 % |
Q1 | 2024-05-07 | $2.29 | $2.15 | 6.51 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-13 | $667.50M | $679.75M | -1.80 % |
Q3 | 2024-10-30 | $649.73M | $628.17M | 3.43 % |
Q2 | 2024-08-01 | $638.48M | $645.79M | -1.13 % |
Q1 | 2024-05-07 | $610.82M | $619.09M | -1.34 % |
Bio-Rad Laboratories (BIO) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 13, 2025 for Q4.
The Actual EPS was $2.90, which beat the estimate of $2.88.
The Actual Revenue was $667.5M, which missed the estimate of $679.8M.
Browse earnings estimates, EPS, and revenue on all stocks.